Wuhan Pioon Technology Co., Ltd. appears in FDA premarket notification records as the applicant for medical diode laser devices regulated under 21 CFR 878.4810 as powered laser surgical instruments for general and plastic surgery and dermatology. The supplied collection, retrieved as of 20 November 2026, contains one linked 510(k) record, K262426, with a substantially equivalent decision dated 10 September 2026. That single-record count describes the supplied filings only and is not a measure of company sales, total portfolio or safety performance. [1][2][5]
The 2026 clearance and its device family
K262426 covers a device named Medical Diode Laser with four model designations: S1Pro+, S1Pro K15, S1Pro N6 and S1Pro N75. The submission was received on 16 July 2026 and decided on 10 September 2026 as substantially equivalent, under product code GEX, with the advisory committee recorded as General and Plastic Surgery. The clearance type is Traditional, the third-party review flag is No, and the statement or summary field reads Summary. [1][2]
The FDA record lists Wuhan Pioon Technology Co., Ltd. as the applicant, with a Wuhan city entry and a contact name in the filing data. The correspondence address on the filing is not evidence of a corporate headquarters, and no headquarters location is established here beyond what the filings state. [1][5]
Earlier S1Pro submissions
Two earlier FDA documents in the public documents concern a Medical Diode Laser, Model S1Pro, also under 21 CFR 878.4810. A 3 August 2023 letter responds to K231548, and a 10 June 2024 letter responds to K240644, stating that the S1Pro is considered substantially equivalent to the predicate devices and that differences in parameters do not raise new types of questions regarding safety and effectiveness for the proposed indications for use. [5][8]
The 2023 letter records a software level of concern described as moderate, with documentation provided accordingly. These letters are filing correspondence; they do not establish commercial availability, installed base or clinical performance of any model. [8]
Published product descriptions
Pioon's own product page describes the S1Pro Plus as a multi-wavelength surgical diode laser with 980nm and 1470nm mixed emission in one platform, positioned by the publisher as balancing tissue ablation with coagulation support, in a compact and lightweight design. The same page identifies Wuhan Pioon Technology Co., Ltd. as the original manufacturer and lists a Wuhan address and sales contact. These are publisher statements, not independently verified specifications. [3]
A separate Pioon page for the S1Pro 1470nm diode laser lists a 1470nm ±10nm wavelength, 12W power and a 7-inch touch display, and states that Pioon has supplied hundreds of laser devices to nearly 10,000 users worldwide. That user figure is the publisher's own claim and is not corroborated by the FDA records in the public documents. [7]
Stated application areas and identity
Pioon's site navigation lists clinical application categories including dentistry, vascular, ENT surgery, orthopedics, gynecology, proctology, dermatology, podiatry, skin and aesthetic, ophthalmology, veterinary medicine and laser therapy, alongside medical laser fibers, handpieces and accessories. The company describes itself as focused on diode laser technology and its clinical applications. Category listings indicate marketed subject areas, not cleared indications for any specific model. [4][6]
The FDA records name Wuhan Pioon Technology Co., Ltd. as the legal applicant; no parent company, brand owner or affiliated entity is verified in the public documents, and the Pioon brand pages are attributed to the company itself. [1][3][6]
